Telcon Inc (200230) fair value: what the stock is really worth
As of Nov 19, 2026: fair value (intrinsic value) of Telcon Inc stock KRW 3,978, price KRW 1,765, upside +125.4%, quality 43 out of 100. Rating: strongly undervalued. Calculated from audited financials with 13 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Telcon Inc
200230 · KQCheap (56% below fair value), but weak company and falling price: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.
How to read this chart
60‑month range 1,765 KRW – 140,723 KRW · fair‑value band 3,853 KRW – 4,088 KRW · the 1,765 KRW price screens below the 3,978 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 16, 2026.
Every Wednesday you see whether Telcon is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
TELCON RF PHARMACEUTICAL. Inc. primarily engages in the development, production, and sale of RF coaxial connectors worldwide. It also provides coaxial couplers, distributors, and arresters, as well as cable assemblies; and pharmaceuticals.
Show moreShow less
The company was formerly known as Telcon Co., Ltd. TELCON RF PHARMACEUTICAL. Inc. was founded in 1999 and is headquartered in Yongin-si, South Korea.
Stock analysis
Telcon Inc (200230) currently trades at 1,765 KRW, while our model-based Fair Value estimate is 3,978 KRW, implying the stock looks roughly 56% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of 17,805 KRW per share, and 10 of the 13 models we run sit above the 1,765 KRW price.
Bear case: the Asset-Based group reads lowest at 1,340 KRW, and 3 of the 13 models stay below the price. Data coverage for this calculation is low.
Scenario range: 3,853 KRW (bear) to 4,088 KRW (bull), the price of 1,765 KRW sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 43/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Telcon Inc reported revenue of 43.2B KRW in FY2025 versus 37.8B KRW in FY2021, a compound +3.3%/yr. Reported net income was −11.5B KRW in FY2025.
Key figures
Market cap 12.6B KRW (≈ $9.5M) Micro · P/S ratio 0.23 · EPS (TTM) −2,206 KRW · Net margin −28.3% · Return on equity −32.7% · Return on assets (EBIT) −4.2% (5-year average) · Operating margin −2.8% · Revenue (TTM) 61.8B KRW.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 18 out of 100 (medium confidence).
What moves the price
The share trades about 84% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at 125%, 200230 screens cheaper than that median.
Fair Value models
All 13 models by family
The fair value above starts from this blend and is adjusted for dilution from new shares.
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
Watch 200230, get fair value alerts →
Compare Telcon Inc with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 608 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Information Technology sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Quality Score by industry
- Return on equity by industry
- Piotroski F-Score screener with fair value
- Undervalued stocks: South Korean Stocks
- Valuation of the Korea market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $85.57 | $113.53 | +33% | vs 200230 |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥46.88 | ¥52.43 | +12% | vs 200230 |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,900 | ₹1,983 | +4% | vs 200230 |
| Haleon plc HLN | $9.08 | $8.47 | −7% | vs 200230 |
| Merck KGaA MRK | €148.40 | €108.83 | −27% | vs 200230 |
| Galderma Group GALD | CHF 184.70 | CHF 112.46 | −39% | vs 200230 |
| Takeda Pharmaceutical Company TAK | $21.27 | $11.23 | −47% | vs 200230 |
| Sandoz Group SDZ | CHF 81.24 | CHF 41.06 | −49% | vs 200230 |
| Teva Pharmaceutical Industries Limited TEVA | $42.23 | $20.74 | −51% | vs 200230 |
| Divi's Laboratories Limited DIVISLAB | ₹11,178 | ₹1,567 | −86% | vs 200230 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Telcon Inc (200230) overvalued or undervalued?
What is the fair value of 200230?
What is the quality score of 200230?
What is the price target for Telcon Inc (200230)?
What is the Telcon Inc stock forecast for 2026?
What is the revenue of Telcon Inc (200230)?
What growth is priced into Telcon Inc (200230)?
What discount rate (WACC) does the fair value of 200230 use?
What is a reverse DCF?
How much growth has Telcon Inc (200230) delivered so far?
How fast is the sector of Telcon Inc (200230) growing?
What is the free cash flow yield of Telcon Inc (200230)?
What is the intrinsic value of Telcon Inc (200230)?
Is Telcon Inc stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 200230?
How much is Telcon Inc worth?
What do the bullish and bearish scenarios say about 200230?
How solid is the balance sheet of Telcon Inc (200230)?
How far is 200230 from its 52-week high?
Which stocks are comparable to Telcon Inc?
Is Telcon Inc stock attractive at the current price?
How is the fair value of 200230 calculated?
Is it still worth investing in stocks now?
What is the share price of Telcon Inc (200230)?
What should I pay attention to with Telcon Inc right now?
Key figures of Telcon Inc
How large is the market capitalisation of Telcon Inc (200230)?
What is the P/S ratio of Telcon Inc (200230)?
What are the earnings per share of Telcon Inc (200230)?
What is the net margin of Telcon Inc (200230)?
What is the return on equity of Telcon Inc (200230)?
What is the EBIT return on assets of Telcon Inc (200230)?
What is the operating margin of Telcon Inc (200230)?
How fast is revenue growing at Telcon Inc (200230)?
How fast are earnings growing at Telcon Inc (200230)?
How much net debt does Telcon Inc (200230) carry?
Watch Telcon Inc in the live analysis
One click puts Telcon Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.